sharetrader
  1. #15911
    Antiquated & irrational t.rexjr's Avatar
    Join Date
    Feb 2017
    Location
    Under the sycamore tree
    Posts
    593

  2. #15912
    Member
    Join Date
    Nov 2015
    Posts
    242

    Default

    But there is still good news afoot.

    Pacific Edge Named 20th in Deloitte Fast50

    The team at Dunedin cancer diagnostics company, Pacific Edge, is celebrating today after being named the 20th fastest growing company in the Deloitte Fast50 Awards, coming in with 324% growth in revenue over three years.

    Pacific Edge is the first company in the world to offer a suite of molecular diagnostic tests which cover all areas of the clinical pathway for bladder cancer. Since commencing commercial sales in 2013, it has consistently increased year-on-year revenue growth, reflecting ever increasing demand for its simple to use, non-invasive and effective bladder cancer diagnostics technology, Cxbladder.

    Backed by a growing library of peer reviewed clinical papers, urologists and clinicians are recognising the validity and utility of this new technology and uptake is increasing, particularly in Pacific Edge’s primary market, the United States, and its home market in New Zealand.

    The combination of its novel technology, focus on clinical validation and careful targeting of key customers has seen Pacific Edge achieve triple-digit growth for the past three years.

    CEO David Darling and CFO Kate Rankin accept the award at the Deloitte Festival of Growth in Auckland last night. Excuse the photographer in the photo, we're still awaiting our official shots from the event but couldn't wait to share this news with all of you!

    CEO of Pacific Edge, David Darling, said: “We are delighted to be included in the Deloitte Fast50 index. It is a great recognition for the hard work and dedication of our team over the last few years.

    “What is especially rewarding is that we have successfully developed a world leading suite of diagnostic tests using an innovative new technology and are now monetising these great products for our shareholders.

    “From the beginning we have been focused on enabling better care and outcomes for patients by providing more effective, highly accurate and non-invasive tests which allow for more informed decision making by clinicians. Use of our Cxbladder products is resulting in a reduction in the total number of procedures and a lower number of invasive procedures and therefore, a lower cost and better allocation of limited healthcare resources.

    “The most exciting thing for Pacific Edge is the traction we are gaining in the US, the world’s largest healthcare market and the recognition we are receiving from urologists around the world who are great advocates for our technology. We are still in the early stages of our commercial journey and we see a bright future ahead of us.”

  3. #15913
    Legend Balance's Avatar
    Join Date
    Feb 2003
    Posts
    21,636

    Default

    Quote Originally Posted by When the bass drops View Post
    We are still in the early stages of our commercial journey and we see a bright future ahead of us.”
    4 years on from the launch of the commercialization, the quote above pretty much sums up the parallel universe that DD and PEB live in.

    Conclusive proof of the parallel universe : "Pacific Edge Chairman Chris Swann says the funds raised will provide funding to implement the roll out of the US sales force in pursuit of achieving $100 million of commercial sales of Cxbladder in the United States within five trading years.

    "The Board is fully confident that the funds being raised will be sufficient to cover operating expenses until Pacific Edge achieves profitability."

    Stated in October 2013 while encouraging shareholders to front up with more cash.

    As W69 observed rather accurately, PEB time is on a different dimension to the rest of us normal human beings. Obviously some of the shareholders and institutions out there live some time in PEB's 10th time dimension?
    Last edited by Balance; 10-11-2017 at 04:43 PM.

  4. #15914
    Legend Balance's Avatar
    Join Date
    Feb 2003
    Posts
    21,636

    Default

    https://www.nzx.com/announcements/310151

    So shortfall cleared at 32c.

    So who is the company and underwriters trying to kid? Market share price was 35c and if that was a realistic and sustainable price, every freaking man and their granduncle would have paid at least 33c for the shares!

    Bet you that the underwriter had a few ' friendly' parties bid for the shortfall to make the issue declared as successful.

    NZX and FMA - are you investigating the blatant sp massaging here to assess whether it constitutes market manipulation?

  5. #15915
    Senior Member hardt's Avatar
    Join Date
    Apr 2017
    Location
    In a bubble
    Posts
    726

    Default

    Quote Originally Posted by Balance View Post
    https://www.nzx.com/announcements/310151

    So shortfall cleared at 32c.

    So who is the company and underwriters trying to kid? Market share price was 35c and if that was a realistic and sustainable price, every freaking man and their granduncle would have paid at least 33c for the shares!

    Bet you that the underwriter had a few ' friendly' parties bid for the shortfall to make the issue declared as successful.

    NZX and FMA - are you investigating the blatant sp massaging here to assess whether it constitutes market manipulation?
    What can the FMA possibly do to someone supporting bids on market?

  6. #15916
    Legend Balance's Avatar
    Join Date
    Feb 2003
    Posts
    21,636

    Default

    Quote Originally Posted by hardt View Post
    What can the FMA possibly do to someone supporting bids on market?
    Precisely why the FMA should investigate and put an end to this practice during rights issue.

  7. #15917
    AWOL
    Join Date
    Sep 2012
    Location
    Vacation
    Posts
    2,782

    Default

    Conclusive proof of the parallel universe : "Pacific Edge Chairman Chris Swann says the funds raised will provide funding to implement the roll out of the US sales force in pursuit of achieving $100 million of commercial sales of Cxbladder in the United States within five trading years
    .
    What would you have preferred he said?

    "Pacific Edge Chairman Chris Swann says he doubts the funds raised will provide funding to implement the roll out of the US sales force in pursuit of achieving $100 million of commercial sales of Cxbladder in the United States within a highly unlikely five trading years"

    Get back to us after 5 trading years, in the meantime put a sock in it Mr 5 bucks a share

  8. #15918
    AWOL
    Join Date
    Sep 2012
    Location
    Vacation
    Posts
    2,782

    Default

    Quote Originally Posted by Balance View Post
    I have taken my 50T sells at 69c and 70c out - they have done the job of spooking these traders out of their stock at breakeven or below breakeven price.
    Hmmmm- very interesting.

  9. #15919
    Guru
    Join Date
    Jul 2002
    Location
    New Zealand.
    Posts
    4,456

    Default

    Now that the issue is out of the way I note that the S P is slowly slipping , I wonder how long it will take until it is below the issue price, hush how dare you say that , are you a non believer !!
    Where is FNZCap !!

  10. #15920
    Guru
    Join Date
    Jul 2002
    Location
    New Zealand.
    Posts
    4,456

    Default

    Another 1/2 cent lower quote today, Im wondering if the underwriters are slowly letting the price slip down to the issue price, could it go lower than the .32 issue price ?

Tags for this Thread

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •